79 related articles for article (PubMed ID: 12124245)
1. False positive uptake of metaiodobenzylguanidine in hepatocellular carcinoma.
Inoue Y; Akahane M; Kitazawa T; Ijichi H; Obi S; Yoshikawa K; Ohtomo K; Omata M
Br J Radiol; 2002 Jun; 75(894):548-51. PubMed ID: 12124245
[TBL] [Abstract][Full Text] [Related]
2. Increased uptake of (131)I-MIBG after intra-arterial application in liver metastases of a neuroendocrine tumor.
Popp M; Strumpf A; Zöphel K; Stroszczynski C; Kotzerke J
Eur J Nucl Med Mol Imaging; 2010 Jan; 37(1):180. PubMed ID: 19789869
[No Abstract] [Full Text] [Related]
3. Factors predicting tracer uptake in somatostatin receptor and MIBG scintigraphy of metastatic gastroenteropancreatic neuroendocrine tumors.
Ezziddin S; Logvinski T; Yong-Hing C; Ahmadzadehfar H; Fischer HP; Palmedo H; Bucerius J; Reinhardt MJ; Biersack HJ
J Nucl Med; 2006 Feb; 47(2):223-33. PubMed ID: 16455627
[TBL] [Abstract][Full Text] [Related]
4. Cotransfecting norepinephrine transporter and vesicular monoamine transporter 2 genes for increased retention of metaiodobenzylguanidine labeled with iodine 131 in malignant hepatocarcinoma cells.
Zhao Y; Zhong X; Ou X; Cai H; Wu X; Huang R
Front Med; 2017 Mar; 11(1):120-128. PubMed ID: 28213878
[TBL] [Abstract][Full Text] [Related]
5. 123I-Metaiodobenzylguanidine uptake in the nape of the neck of children: likely visualization of brown adipose tissue.
Okuyama C; Ushijima Y; Kubota T; Yoshida T; Nakai T; Kobayashi K; Nishimura T
J Nucl Med; 2003 Sep; 44(9):1421-5. PubMed ID: 12960186
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m sestamibi uptake in hepatocellular carcinoma.
Derebek E
Eur J Nucl Med; 1998 Nov; 25(11):1587-8. PubMed ID: 9882185
[No Abstract] [Full Text] [Related]
7. 11C-acetate: a new tracer for the evaluation of hepatocellular carcinoma.
Delbeke D; Pinson CW
J Nucl Med; 2003 Feb; 44(2):222-3. PubMed ID: 12571213
[No Abstract] [Full Text] [Related]
8. False-positive radio-iodinated metaiodobenzylguanidine (123I-MIBG) accumulation in a mast cell-infiltrated infantile haemangioma.
Rottenburger C; Juettner E; Harttrampf AC; Hentschel M; Kontny U; Roessler J
Br J Radiol; 2010 Aug; 83(992):e168-71. PubMed ID: 20675460
[TBL] [Abstract][Full Text] [Related]
9. Increased MIBG uptake after transfer of the human norepinephrine transporter gene in rat hepatoma.
Altmann A; Kissel M; Zitzmann S; Kübler W; Mahmut M; Peschke P; Haberkorn U
J Nucl Med; 2003 Jun; 44(6):973-80. PubMed ID: 12791828
[TBL] [Abstract][Full Text] [Related]
10. False positive metaiodobenzylguanidine scan in a patient with a huge adrenocortical carcinoma.
Rainis T; Ben-Haim S; Dickstein G
J Clin Endocrinol Metab; 2000 Jan; 85(1):5-7. PubMed ID: 10634355
[TBL] [Abstract][Full Text] [Related]
11. Meta-[131I]iodobenzylguanidine in the scintigraphic evaluation of neural crest tumors.
Zagar I; Han R; Mitrovic S
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):13-6. PubMed ID: 9002742
[TBL] [Abstract][Full Text] [Related]
12. Uptake of
Bhanthumkomol P; Hijioka S; Mizuno N; Kuwahara T; Okuno N; Ito A; Tanaka T; Ishihara M; Hirayama Y; Onishi S; Niwa Y; Tajika M; Ito Y; Sasaki E; Inaba Y; Shimizu Y; Yatabe Y; Hara K
Clin J Gastroenterol; 2017 Aug; 10(4):364-370. PubMed ID: 28447327
[TBL] [Abstract][Full Text] [Related]
13. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses.
Ho CL; Yu SC; Yeung DW
J Nucl Med; 2003 Feb; 44(2):213-21. PubMed ID: 12571212
[TBL] [Abstract][Full Text] [Related]
14. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of 123I-MIBG after acute myocardial infarction and reperfusion therapy.
Bengel FM; Barthel P; Matsunari I; Schmidt G; Schwaiger M
J Nucl Med; 1999 Jun; 40(6):904-10. PubMed ID: 10452304
[TBL] [Abstract][Full Text] [Related]
16. MIBG and radiolabeled octreotide in neuroendocrine tumors.
Hoefnagel CA
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):137-9. PubMed ID: 9002773
[TBL] [Abstract][Full Text] [Related]
17. Persistent intense MIBG activity in the liver caused by prior radiation.
Yang J; Codreanu I; Servaes S; Zhuang H
Clin Nucl Med; 2014 Oct; 39(10):926-30. PubMed ID: 24999695
[TBL] [Abstract][Full Text] [Related]
18. A meta-iodobenzylguanidine scintigraphic scoring system increases accuracy in the diagnostic management of pheochromocytoma.
Cecchin D; Lumachi F; Marzola MC; Opocher G; Scaroni C; Zucchetta P; Mantero F; Bui F
Endocr Relat Cancer; 2006 Jun; 13(2):525-33. PubMed ID: 16728579
[TBL] [Abstract][Full Text] [Related]
19. Enhanced tumor uptake in neuroendocrine tumors after intraarterial application of 131I-MIBG.
Brogsitter C; Pinkert J; Bredow J; Kittner T; Kotzerke J
J Nucl Med; 2005 Dec; 46(12):2112-6. PubMed ID: 16330578
[TBL] [Abstract][Full Text] [Related]
20. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
Kaltsas G; Korbonits M; Heintz E; Mukherjee JJ; Jenkins PJ; Chew SL; Reznek R; Monson JP; Besser GM; Foley R; Britton KE; Grossman AB
J Clin Endocrinol Metab; 2001 Feb; 86(2):895-902. PubMed ID: 11158063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
